Company research
Stablecoin Development Corp
CIK 1389545Updated Oct 30, 2026
SecuritySDEV · NYSE_AMERICAN · equity
Name history
NovaBay Pharmaceuticals, Inc. · through Mar 23, 2026
SDEV price & chart
Loading TradingView…
AMEX:SDEV on TradingView ↗In the news
These High-Voltage Stocks Are Suddenly Impossible to Ignore ↗
Recent filings
Results of Operations and Financial Condition · Regulation FD Disclosure
Items 2.02, 7.01, 9.01
10-Q filing
S-3/A filing
S-3/A filing
Results of Operations and Financial Condition · Other Events
Items 2.02, 8.01, 9.01
Show 5 more recent filings
Other Events
Items 8.01, 9.01
DEF 14A filing
S-3/A filing
Material Modification to Rights of Security Holders · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Items 3.03, 5.02, 5.03, 9.01
SCHEDULE 13D/A - filed by Sky Frontier Foundation regarding Stablecoin Development Corp
Financials
FY 2025 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 3,487,000Source | 3,877,000Source | 127,514,000Source | 6,911,000Source | 3,925,000Source | 179,743,000Source | 9,872,000Source | 5,357,000Source | 9,035,000Source | 3,423,000Source | 9,034,000Source | 16,399,000Source |
| Property, Plant and Equipment, NetUSD | 6,000Source | 61,000Source | — | 11,000Source | 44,000Source | — | 12,000Source | 44,000Source | — | 53,000Source | 87,000Source | 119,000Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 348,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | 0Source | 2,280,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 2,309,000Source | 776,000Source | 6,968,000Source | 5,344,000Source | 751,000Source | 18,405,000Source | 8,467,000Source | 1,823,000Source | 7,958,000Source | 430,000Source | 3,130,000Source | 5,362,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 704,000Source | — | — | 547,000Source | — | — | 734,000Source | — | — | 759,000Source | — |
| Inventory, NetUSD | — | 473,000Source | — | 467,000Source | 700,000Source | — | — | 663,000Source | — | 765,000Source | 2,877,000Source | 3,437,000Source |
| Assets, CurrentUSD | 2,898,000Source | 2,279,000Source | 8,095,000Source | 6,115,000Source | 2,253,000Source | 19,053,000Source | 9,038,000Source | 3,591,000Source | 8,675,000Source | 1,935,000Source | 7,154,000Source | 11,332,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 221,000Source | 326,000Source | 1,127,000Source | 304,000Source | 255,000Source | 648,000Source | 571,000Source | 371,000Source | 717,000Source | 303,000Source | 388,000Source | 560,000Source |
| Operating Lease, Right-of-Use AssetUSD | 189,000Source | 1,042,000Source | — | 306,000Source | 1,128,000Source | — | 343,000Source | 1,212,000Source | 0Source | 955,000Source | 1,296,000Source | 1,831,000Source |
| Other Assets, NoncurrentUSD | 394,000Source | 495,000Source | 177,000Source | 479,000Source | 476,000Source | 604,000Source | 479,000Source | 477,000Source | 360,000Source | 480,000Source | 497,000Source | 489,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 1,853,000Source | 2,805,000Source | 270,000Source | 2,666,000Source | 4,542,000Source | 40,918,000Source | 3,705,000Source | 5,197,000Source | 640,500,000Source | 3,552,000Source | 5,720,000Source | 5,845,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 60,000Source | 49,000Source | 506,000Source | 58,000Source | 13,000Source | 267,000Source | 58,000Source | 320,000Source | — | 49,000Source | 112,000Source | 652,000Source |
| Additional Paid in CapitalUSD | 181,074,000Source | 183,262,000Source | 434,459,000Source | 181,890,000Source | 179,392,000Source | 405,209,000Source | 181,890,000Source | 176,798,000Source | 186,981,000Source | 183,273,000Source | 176,101,000Source | 165,081,000Source |
| Retained Earnings (Accumulated Deficit)USD | -183,817,000Source | -182,245,000Source | -307,721,000Source | -177,709,000Source | -180,028,000Source | -266,651,000Source | -175,787,000Source | -178,443,000Source | -819,054,000Source | -183,457,000Source | -174,849,000Source | -158,152,000Source |
| Stockholders' Equity Attributable to ParentUSD | 1,109,000Source | 1,072,000Source | 127,244,000Source | 4,245,000Source | -617,000Source | 138,825,000Source | 6,167,000Source | 160,000Source | -631,815,000Source | -129,000Source | 3,314,000Source | 10,554,000Source |
| Liabilities and EquityUSD | 3,487,000Source | 3,877,000Source | 127,514,000Source | 6,911,000Source | 3,925,000Source | 179,743,000Source | 9,872,000Source | 5,357,000Source | 9,035,000Source | 3,423,000Source | 9,034,000Source | 16,399,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 1,448,000Source | 1,984,000Source | 270,000Source | 2,144,000Source | 3,610,000Source | 3,576,000Source | 3,067,000Source | 3,924,000Source | 1,142,000Source | 2,843,000Source | 4,278,000Source | 4,257,000Source |
| Operating Lease, Liability, CurrentUSD | 416,000Source | 390,000Source | 0Source | 409,000Source | 382,000Source | 471,000Source | 403,000Source | 375,000Source | 422,000Source | 398,000Source | 495,000Source | 453,000Source |
| Accounts Payable, CurrentUSD | 76,000Source | 396,000Source | 0Source | 604,000Source | 1,235,000Source | 1,978,000Source | 800,000Source | 1,117,000Source | 257,000Source | 623,000Source | 1,130,000Source | 1,080,000Source |
| Operating Lease, Liability, NoncurrentUSD | 405,000Source | 821,000Source | 0Source | 522,000Source | 932,000Source | 166,000Source | 638,000Source | 1,041,000Source | 287,000Source | 709,000Source | 1,108,000Source | 1,588,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 807,000Source | 1,147,000Source | 270,000Source | 1,020,000Source | 1,297,000Source | 1,127,000Source | 1,780,000Source | 1,266,000Source | 396,000Source | 1,257,000Source | 1,516,000Source | 2,724,000Source |
| Deferred Income Tax Liabilities, Net | — | — | — | — | — | —Source | — | — | — | — | — | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | — | — | — | — | 51,000Source | 120,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | 0Source | — | -291,000Source | -1,214,000Source | 305,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | — | 0Source | — | 272,000Source | -560,000Source | 217,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -1,804,000Source | -1,324,000Source | -8,430,000Source | — | -4,131,000Source | -6,654,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -25,918,000Source | 0Source | — | 1,064,000Source | -19,000Source | -112,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | — | 0Source | — | 6,000Source | 19,000Source | 112,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 38,337,000Source | -1,708,000Source | 4,615,000Source | 1,500,000Source | 1,910,000Source | 4,633,000Source |
| Dividends paid | — | — | — | — | — | — | — | — | —Source | — | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 10,615,000Source | 8,037,000Source | 7,318,000Source | -2,699,000Source | -2,240,000Source | -2,133,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 2,702,000Source | 1,253,000Source | 7,122,000Source | 5,821,000Source | 18,840,000Source | 8,944,000Source | 8,225,000Source | 907,000Source | — | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 0Source | 8,000Source | 8,000Source | 147,000Source | 326,000Source | 17,000Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | — | — | 359,000Source | 24Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | 22,000Source | — | — | — | — | 29,000Source | 148,000Source | 291,000Source | — |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | 0Source | 138,000Source | — | 0Source | — | 0Source | 277,000Source | 904,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 152,000Source | 152,000Source | 363,000Source |
| DepreciationUSD | — | — | 1,000Source | 1,000Source | — | 1,000Source | — | 2,000Source | — | 40,000Source | 51,000Source | — |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 561,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | 209,000Source | 0Source | — | — | — | 137,000Source | — | -25,000Source | — | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | 0Source | — | — | — | — | — | -865,000Source | — | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | -13,000Source | — | — | — | — | 0Source | -13,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 1,211,000Source | 1,703,000Source | 5,417,000Source | 1,891,000Source | 2,848,000Source | 2,701,000Source | 7,585,000Source | 7,379,000Source | 6,330,000Source | 7,489,000Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 348,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | 0Source | — | — | — | — | — | — | 2,593,000Source | 6,737,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 348,000Source | 4,180,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | 2,100,000Source | 2,100,000Source | 2,557,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 970,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -1,333,000Source | -1,854,000Source | -41,070,000Source | -1,964,000Source | 552,403,000Source | -3,330,000Source | -641,861,000Source | -7,210,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 40,000Source | 642,000Source | 0Source | 42,000Source | 0Source | 11,000,000Source | 11,081,000Source | -124,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | -3,482,000Source | 0Source | 3,454,000Source | 0Source | 0Source | 0Source | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,293,000Source | -1,212,000Source | -41,070,000Source | -1,922,000Source | 552,403,000Source | 7,670,000Source | -630,780,000Source | -7,223,000Source | -9,640,000Source | -10,608,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -1,293,000Source | -2,217,000Source | -41,070,000Source | -1,922,000Source | 552,403,000Source | 7,670,000Source | -630,780,000Source | -8,608,000Source | -16,697,000Source | -16,265,000Source |
| Operating ExpensesUSD | — | — | 1,298,000Source | 1,703,000Source | 5,417,000Source | 1,891,000Source | 2,848,000Source | 3,290,000Source | 8,439,000Source | 12,320,000Source | 15,491,000Source | 22,198,000Source |
| Operating Lease, Impairment LossUSD | — | — | 84,000Source | — | — | — | — | 559,000Source | 815,000Source | — | — | — |
| Other Nonoperating Income (Expense)USD | — | — | -77,000Source | 0Source | 0Source | -73,000Source | -1,422,000Source | -40,000Source | -20,000Source | -550,000Source | -2,064,000Source | -276,000Source |
| Payments for Repurchase of WarrantsUSD | — | — | 525,000Source | — | — | — | 0Source | 1,815,000Source | 2,001,000Source | — | — | — |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 521,000Source | 0Source | 2,206,000Source | 0Source | 2,463,000Source | 0Source | — | 9,781,000Source | 14,726,000Source | 14,404,000Source |
| Stock or Unit Option Plan ExpenseUSD | — | — | — | — | — | — | 25,000Source | 2,000Source | 29,000Source | 148,000Source | 291,000Source | — |
| Gain (Loss) on Termination of Lease | — | — | — | — | —Source | — | — | — | — | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of RevenueUSD | — | — | 479,000Source | 0Source | — | — | — | — | — | 3,300,000Source | 6,831,000Source | 6,623,000Source |
| Operating Income (Loss)USD | — | — | -1,256,000Source | -1,703,000Source | -53,844,000Source | -1,891,000Source | 22,289,000Source | -3,290,000Source | -8,439,000Source | -5,839,000Source | -7,596,000Source | -14,417,000Source |
| Other Nonoperating Income (Expense)USD | — | — | -77,000Source | 0Source | 0Source | -73,000Source | -1,422,000Source | -40,000Source | -20,000Source | -550,000Source | -2,064,000Source | -276,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | -44,552,000Source | -1,964,000Source | 555,857,000Source | -3,330,000Source | — | — | -9,640,000Source | -10,608,000Source |
| Income Tax Expense (Benefit)USD | — | — | 0Source | 0Source | -3,482,000Source | 0Source | 3,454,000Source | 0Source | 0Source | 0Source | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -1,293,000Source | -1,212,000Source | -41,070,000Source | -1,922,000Source | 552,403,000Source | 7,670,000Source | -630,780,000Source | -7,223,000Source | -9,640,000Source | -10,608,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.22Source | -1.92Source | -1.32Source | -1.65Source | 21.23Source | 7.22Source | -108.39Source | -2.53Source | -3.96Source | -10.1Source |
| Total Revenue | — | — | — | — | — | — | — | — | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 5,876,000Source | 1,155,000Source | 31,048,000Source | 1,164,000Source | 26,015,000Source | 1,062,000Source | 5,820,000Source | 3,396,000Source | 4,215,000Source | 1,610,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | 152,000Source | 152,000Source | 363,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 1,211,000Source | 1,703,000Source | 5,417,000Source | 1,891,000Source | 2,848,000Source | 2,701,000Source | 7,585,000Source | 7,379,000Source | 6,330,000Source | 7,489,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | 348,000Source | 4,180,000Source |
| Gross ProfitUSD | — | — | 42,000Source | 0Source | — | — | — | — | — | 6,481,000Source | 7,895,000Source | 7,781,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | — | — | -1,333,000Source | -1,854,000Source | -41,070,000Source | -1,964,000Source | 552,403,000Source | -3,330,000Source | -641,861,000Source | -7,210,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -641,861,000Source | -7,223,000Source | -9,640,000Source | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.23Source | -2.48Source | -1.32Source | -1.69Source | 21.23Source | -3.14Source | -110.29Source | -2.53Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to ParentUSD | — | — | 40,000Source | 642,000Source | 0Source | 42,000Source | 0Source | 11,000,000Source | 11,081,000Source | -124,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -1,293,000Source | -2,217,000Source | -41,070,000Source | -1,922,000Source | 552,403,000Source | 7,670,000Source | -630,780,000Source | -8,608,000Source | -16,697,000Source | -16,265,000Source |
| Operating ExpensesUSD | — | — | 1,298,000Source | 1,703,000Source | 5,417,000Source | 1,891,000Source | 2,848,000Source | 3,290,000Source | 8,439,000Source | 12,320,000Source | 15,491,000Source | 22,198,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Research and Development ExpenseUSD | — | — | — | 4,000Source | — | — | — | — | — | 42,000Source | 68,000Source | 174,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 521,000Source | 0Source | 2,206,000Source | 0Source | 2,463,000Source | 0Source | — | 9,781,000Source | 14,726,000Source | 14,404,000Source |
| Selling and Marketing ExpenseUSD | — | — | — | 947,000Source | — | — | — | — | — | 4,034,000Source | 6,500,000Source | 7,798,000Source |
| Earnings Per Share, Diluted | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Common Stock, Dividends, Per Share, Declared | — | — | —Source | — | — | — | — | — | — | — | — | — |
| Income (Loss) from Continuing Operations, Per Diluted Share | — | — | —Source | —Source | —Source | —Source | —Source | —Source | — | — | — | — |
| Nonoperating Income (Expense) | — | — | — | — | —Source | —Source | —Source | —Source | — | — | — | — |
Offerings
Registration 333-298229
Filing attachments
novabay_ex99-1.htm · 8-K · 2025-10-21
EX-99.1 2 novabay_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NovaBay Pharmaceuticals, Inc. Regains Compliance with NYSE American Continued Listing Standards EMERYVILLE, Calif. (October 20, 2025) - NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that it has regained compliance with the NYSE American’s continued listing standards. As previously disclosed, the NYSE American notified the Company on April 18, 2024 and May 28, 2024 that it was not in complian…
Read attachment ↗novabay_ex4-1.htm · 8-K · 2025-10-20
EX-4.1 3 novabay_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE, AND, ACCORDINGLY,…
Read attachment ↗novabay_ex99-1.htm · 8-K · 2025-09-18
EX-99.1 2 novabay_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting EMERYVILLE, Calif. (September 18, 2025) - NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (the “Company”) previously announced a one-time special cash dividend of $0.80 per share for the Company’s common stock. The special cash dividend will be payable on September 29, 2025 to stockholders of …
Read attachment ↗novabay_ex99-1.htm · 8-K · 2025-08-26
EX-99.1 2 novabay_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share EMERYVILLE, Calif. (August 26, 2025) - NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board of Directors has declared a one-time special cash dividend of $0.80 per share of common stock. The special cash dividend will be payable on September …
Read attachment ↗novabay_ex99-1.htm · 8-K · 2025-08-19
EX-99.1 14 novabay_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 August 19, 2025 NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement with Investor David E. Lazar Investment to support NovaBay’s continued public listing and provide funding for a future strategic transaction EMERYVILLE, Calif. (August 19, 2025) - NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces it has entered into a $6 million securities purchase agreement with pri…
Read attachment ↗